 |
International Journal for Research Trends and Innovation
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2456-3315 | Impact factor: 8.14 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.14 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)
|
Issue: December 2025
Volume 10 | Issue 12
Review Result and Publication of Paper within : 2-3 days
Click Here For more DetailsFor Authors
Forms / Download
Published Issue Details
Editorial Board
Other IMP Links
Facts & Figure
Impact Factor : 8.14
Issue per Year : 12
Volume Published : 10
Issue Published : 115
Article Submitted : 19444
Article Published : 8041
Total Authors : 21252
Total Reviewer : 769
Total Countries : 144
Indexing Partner
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
|
Published Paper Details
|
|
| Paper Title: | Novel iron formulations for the treatment of Iron deficiency and Iron deficiency anemia |
| Authors Name: | Shahanaz parveen Shaik , Sai kiran Attuluri , Prerna Saini |
| Download E-Certificate: | Download |
| Author Reg. ID: |
IJRTI_188103
|
| Published Paper Id: | IJRTI2309060 |
| Published In: | Volume 8 Issue 9, September-2023 |
| DOI: | |
| Abstract: | Iron deficiency and iron deficiency anemia are one of the major public health problems affecting the quality of life and contributing to significant morbidity and mortality in the patient population. One of the major obstacles in the treatment of iron deficiency is non adherence to the treatment. Current literature further identifies the side effects of the current iron formulations as the main reason contributing to non adherence and treatment failure, hence making it an urgent need to identify newer drugs with less side effects. We have conducted a thorough literature search using Pubmed and Google Scholar and identified four oral and two intravenous iron preparations that yielded the maximum amount of published information. Then a second detailed analysis and information gathering was done on each identified iron preparation focussing on their efficacy and side effect profile.Finally, in this review we reconciled data from over 100 articles within the last ten years to compose subsections with information on each drug. Keywords used were ‘Novel iron preparations’, ‘Ferric carboxy maltose’, ‘Ferric derisomaltose’, ‘Sucrosomial iron’, ‘Ferric citrate’, ‘Ferric maltol' and ‘Liposomal iron’. Data suggests that Oral formulations such as ferric maltol, sucrosomial iron and liposomal iron are associated with fewer side effects when compared to the conventional drugs. Whereas ferric citrate with its action on FGF 23 helps in the treatment of not only iron deficiency with or without anemia but also hyperphosphatemia in Chronic kidney disease. The gastrointestinal side effects of ferric citrate are higher when compared to the current iron medications. Intravenous formulations such as ferric carboxy maltose and ferric der isomaltose have shown to be effective in quickly correcting the iron levels and require lower doses when compared to other IV formulations. In conclusion Liposomal and sucrosomial iron are the most effective oral formulations in terms of efficacy, absorption, associated with lower gastrointestinal side effect profile. Ferric citrate can be used in chronic kidney disease due to its favorable action on FGF 23 and phosphate levels. Ferric carboxy maltose and der isomaltose are intravenous formulations useful in cases requiring quick action and lower absorption or tolerance to oral iron. |
| Keywords: | ‘Novel iron preparations’, ‘Ferric carboxy maltose’, ‘Ferric derisomaltose’, ‘Sucrosomial iron’, ‘Ferric citrate’, ‘Ferric maltol' and ‘Liposomal iron’. |
| Cite Article: | "Novel iron formulations for the treatment of Iron deficiency and Iron deficiency anemia", International Journal of Science & Engineering Development Research (www.ijrti.org), ISSN:2455-2631, Vol.8, Issue 9, page no.445 - 461, September-2023, Available :http://www.ijrti.org/papers/IJRTI2309060.pdf |
| Downloads: | 000205075 |
| ISSN: |
2456-3315 | IMPACT FACTOR: 8.14 Calculated By Google Scholar| ESTD YEAR: 2016 An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.14 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator |
| Publication Details: |
Published Paper ID: IJRTI2309060
Registration ID:188103
Published In: Volume 8 Issue 9, September-2023
DOI (Digital Object Identifier):
Page No: 445 - 461 Country: Guntur, Andhra Pradesh, India Research Area: Health Science Publisher : IJ Publication Published Paper URL : https://www.ijrti.org/viewpaperforall?paper=IJRTI2309060 Published Paper PDF: https://www.ijrti.org/papers/IJRTI2309060 |
| Share Article: | |
|
Click Here to Download This Article |
|
| Article Preview | |
|
|
|
Major Indexing from www.ijrti.org
| Google Scholar | ResearcherID Thomson Reuters | Mendeley : reference manager | Academia.edu |
| arXiv.org : cornell university library | Research Gate | CiteSeerX | DOAJ : Directory of Open Access Journals |
| DRJI | Index Copernicus International | Scribd | DocStoc |
ISSN Details
 |
 |
|
ISSN: 2456-3315
Impact Factor: 8.14 and ISSN APPROVED,
Journal Starting Year (ESTD) : 2016
DOI (A digital object identifier)
| Providing A digital object identifier by DOI.ONE How to Get DOI? |
Conference
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Important Details
Join RMS/Earn 300
WhatsApp
Click Here
Click Here
Indexing Partner |
|||
| Copyright © 2025 - All Rights Reserved - IJRTI | |||